Comparing adults with severe SARS-CoV-2 or influenza infection : South Africa, 2016-2021
dc.contributor.author | Els, Fiona | |
dc.contributor.author | Kleynhans, Jackie | |
dc.contributor.author | Wolter, Nicole | |
dc.contributor.author | Du Plessis, Mignon | |
dc.contributor.author | Moosa, Fahima | |
dc.contributor.author | Tempia, Stefano | |
dc.contributor.author | Makhasi, Mvuyo | |
dc.contributor.author | Nel, Jeremy | |
dc.contributor.author | Dawood, Halima | |
dc.contributor.author | Meiring, Susan | |
dc.contributor.author | Von Gottberg, Anne | |
dc.contributor.author | Cohen, Cheryl | |
dc.contributor.author | Walaza, sibongile | |
dc.date.accessioned | 2024-11-27T04:43:42Z | |
dc.date.available | 2024-11-27T04:43:42Z | |
dc.date.issued | 2024-07-26 | |
dc.description | DATA AVAILABILITY : Data were generated at various facilities in the pneumonia surveillance programme. Derived data supporting the findings of this study are available from the corresponding author, F.E. on request. | en_US |
dc.description.abstract | BACKGROUND : Comparisons of the characteristics of individuals hospitalised with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or seasonal influenza in low-to middleincome countries with high human immunodeficiency virus (HIV) prevalence are limited. OBJECTIVES : Determine the epidemiological differences with those hospitalised with influenza or SARS-CoV-2 infection. METHOD : We investigated hospitalised individuals ≥18 years of age testing positive for seasonal influenza (2016–2019) or SARS-CoV-2 (2020–2021). We used random effects multivariable logistic regression, controlling for clustering by site, to evaluate differences among adults hospitalised with influenza or SARS-CoV-2 infection. RESULTS : Compared to individuals with influenza, individuals with SARS-CoV-2 infection were more likely to be diabetic (adjusted odds ratio [aOR]: 1.70, 95% confidence interval [CI]: 1.11–2.61) or die in hospital (aOR: 2.57, 95% CI: 1.61–4.12). Additionally, those with SARSCoV- 2 infection were less likely to be living with HIV (not immunosuppressed) (aOR: 0.50, 95% CI: 0.34–0.73) or living with HIV (immunosuppressed) (aOR: 0.27, 95% CI: 0.18–0.39) compared to not living with HIV and less likely to be asthmatic (aOR: 0.21, 95% CI: 0.13–0.33) rather than those living with influenza. CONCLUSION : Individuals hospitalised with SARS-CoV-2 had different characteristics to individuals hospitalised with influenza before the coronavirus disease 2019 (COVID-19) pandemic. Risk factors should be considered in health management especially as we move into an era of co-circulation of SARS-CoV-2 and influenza pathogens. CONTRIBUTION : Identifying groups at high risk of severe disease could help to better monitor, prevent and control SARS-CoV-2 or influenza severe disease. | en_US |
dc.description.department | School of Health Systems and Public Health (SHSPH) | en_US |
dc.description.librarian | am2024 | en_US |
dc.description.sdg | SDG-03:Good heatlh and well-being | en_US |
dc.description.sponsorship | The Wellcome Trust; the CDC under the terms of a subcontract with the African Field Epidemiology Network (AFENET), the South African Medical Research Council (SAMRC); the African Society of Laboratory Medicine (ASLM) and Africa Centers for Disease Control and Prevention through a sub-award from the Bill and Melinda Gates Foundation; the National Institute for Communicable Diseases, a division of the National Health Laboratory Service, South Africa. | en_US |
dc.description.uri | http://www.sajid.co.za | en_US |
dc.identifier.citation | Els, F., Kleynhans, J., Wolter, N.. et al. Comparing adults with severe SARS-CoV-2 or influenza infection: South Africa, 2016–2021. Southern African Journal of Infectious Diseases 2024;39(1), a574. https://DOI.org/10.4102/sajid.v39i1.574. | en_US |
dc.identifier.issn | 2312-0053 (print) | |
dc.identifier.issn | 2313-1810 (online) | |
dc.identifier.other | 10.4102/sajid.v39i1.574 | |
dc.identifier.uri | http://hdl.handle.net/2263/99420 | |
dc.language.iso | en | en_US |
dc.publisher | AOSIS | en_US |
dc.rights | © 2024. The Authors. Licensee: AOSIS. This work is licensed under the Creative Commons Attribution License. | en_US |
dc.subject | Pneumonia surveillance | en_US |
dc.subject | Risk factors | en_US |
dc.subject | Severe respiratory illness | en_US |
dc.subject | Pre-pandemic | en_US |
dc.subject | COVID-19 pandemic | en_US |
dc.subject | Coronavirus disease 2019 (COVID-19) | en_US |
dc.subject | Human immunodeficiency virus (HIV) | en_US |
dc.subject | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) | en_US |
dc.subject | SDG-03: Good health and well-being | en_US |
dc.title | Comparing adults with severe SARS-CoV-2 or influenza infection : South Africa, 2016-2021 | en_US |
dc.type | Article | en_US |